Bart Jacobs - Concepedia

Author

Bart Jacobs

Also Known As

B A W Jacobs, B Jacobs, B. Jacobs, B.A.W. Jacobs, Bart A W Jacobs, Bart A. W. Jacobs, Bart A.W. Jacobs, Bart AW Jacobs, Bart Albertus Wilhelmus Jacobs, Bart Jacobs

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Utrecht University Oncode Institute KU Leuven Radboud University Nijmegen

About

Bart Jacobs is an author at The Netherlands Cancer Institute specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	265
2	Health Sciences	1	1	31
3	Public Health	1	1	10
4	Biochemistry	1	1	54
5	Biostatistics	1	1	10

Bart Jacobs

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Amphiregulin and Epiregulin mRNA Expression in Primary Tumors Predicts Outcome in Metastatic Colorectal Cancer Treated With Cetuximab Bart Jacobs, Wendy De Roock, Hubert Piessevaux, Journal of Clinical Oncology	2009	366
PIK3CA Mutations Are Not a Major Determinant of Resistance to the Epidermal Growth Factor Receptor Inhibitor Cetuximab in Metastatic Colorectal Cancer Hans Prenen, Jef De Schutter, Bart Jacobs, Clinical Cancer Research	2009	293
KRAS gene amplification in colorectal cancer and impact on response to EGFR‐targeted therapy Emanuele Valtorta, Sandra Misale, Andrea Sartore‐Bianchi, International Journal of Cancer	2013	176
Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors Max Schreuer, Geert Meersseman, Sari Van Den Herrewegen, Journal of Translational Medicine	2016	136
Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity Didier Meulendijks, Linda M. Henricks, Bart Jacobs, British Journal of Cancer	2017	119
Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With<i>RAS</i>Wild-Type Advanced Colorectal Cancer Jenny F. Seligmann, Faye Elliott, Susan D. Richman, JAMA Oncology	2016	105
A <i>let-7</i> microRNA-Binding Site Polymorphism in <i>KRAS</i> Predicts Improved Outcome in Patients with Metastatic Colorectal Cancer Treated with Salvage Cetuximab/Panitumumab Monotherapy Zenia Saridaki, Joanne B. Weidhaas, Heinz‐Josef Lenz, Clinical Cancer Research	2014	59
Pronounced between‐subject and circadian variability in thymidylate synthase and dihydropyrimidine dehydrogenase enzyme activity in human volunteers Bart Jacobs, Maarten J. Deenen, Dick Pluim, British Journal of Clinical Pharmacology	2016	55
Development and validation of a rapid and sensitive UPLC–MS/MS method for determination of uracil and dihydrouracil in human plasma Bart Jacobs, Hilde Rosing, Niels de Vries, Journal of Pharmaceutical and Biomedical Analysis BiochemistryMedicineBioanalysisMass SpectrometryHuman Plasma	2016	54
Exploring the intracellular pharmacokinetics of the 5‐fluorouracil nucleotides during capecitabine treatment Ellen J. B. Derissen, Bart Jacobs, Alwin D. R. Huitema, British Journal of Clinical Pharmacology	2015	47

Page 1